[HTML][HTML] Long COVID: pathophysiological factors and abnormalities of coagulation

S Turner, MA Khan, D Putrino, A Woodcock… - Trends in Endocrinology …, 2023 - cell.com
Acute COVID-19 infection is followed by prolonged symptoms in approximately one in ten
cases: known as Long COVID. The disease affects~ 65 million individuals worldwide. Many …

[HTML][HTML] More than 50 long-term effects of COVID-19: a systematic review and meta-analysis

S Lopez-Leon, T Wegman-Ostrosky, C Perelman… - Scientific reports, 2021 - nature.com
COVID-19 can involve persistence, sequelae, and other medical complications that last
weeks to months after initial recovery. This systematic review and meta-analysis aims to …

[HTML][HTML] Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients

M Peghin, A Palese, M Venturini, M De Martino… - Clinical Microbiology …, 2021 - Elsevier
Objectives To assess the prevalence of and factors associated with post-coronavirus
disease 2019 (COVID-19) syndrome 6 months after the onset. Methods A bidirectional …

Monocytes and Macrophages in COVID-19

R Knoll, JL Schultze, J Schulte-Schrepping - Frontiers in immunology, 2021 - frontiersin.org
COVID-19 is a contagious viral disease caused by SARS-CoV-2 that led to an ongoing
pandemic with massive global health and socioeconomic consequences. The disease is …

Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment

M Soy, G Keser, P Atagündüz, F Tabak… - Clinical …, 2020 - Springer
COVID-19 infection has a heterogenous disease course; it may be asymptomatic or causes
only mild symptoms in the majority of the cases, while immunologic complications such as …

Laboratory biomarkers for diagnosis and prognosis in COVID-19

D Battaglini, M Lopes-Pacheco… - Frontiers in …, 2022 - frontiersin.org
Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) causes a wide spectrum of
clinical manifestations, with progression to multiorgan failure in the most severe cases …

COVID-19 vaccine frontrunners and their nanotechnology design

YH Chung, V Beiss, SN Fiering, NF Steinmetz - ACS nano, 2020 - ACS Publications
Humanity is experiencing a catastrophic pandemic. SARS-CoV-2 has spread globally to
cause significant morbidity and mortality, and there still remain unknowns about the biology …

The microbial coinfection in COVID-19

X Chen, B Liao, L Cheng, X Peng, X Xu, Y Li… - Applied microbiology …, 2020 - Springer
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel β-coronavirus,
is the main pathogenic agent of the rapidly spreading pneumonia called coronavirus …

Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review

E Ortiz-Prado, K Simbaña-Rivera… - … and infectious disease, 2020 - Elsevier
Coronaviruses are an extensive family of viruses that can cause disease in both animals
and humans. The current classification of coronaviruses recognizes 39 species in 27 …

SARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice

KH Dinnon III, SR Leist, K Okuda, H Dang… - Science translational …, 2022 - science.org
A subset of individuals who recover from coronavirus disease 2019 (COVID-19) develop
post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV …